The pharmacological significance of cannabidiol (CBD) has been in study for numerous years. CBD is the important nonpsychoactive constituent of plant Cannabis sativa and its administration is linked with decreased side effects. Presently, CBD is undergoing a lot of investigation which suggests that it has no addictive effects, excellent security profile and has exhibited strong therapeutic prospective in numerous crucial regions. It has wide spectrum of action for the reason that it acts by way of endocannabinoid receptors CB1 and CB2 and it also acts on other receptors, such as GPR18, GPR55, GPR 119, 5HT1A, and TRPV2. This indicates its therapeutic worth for numerous health-related conditions for the reason that of its neuroprotective and immunomodulatory properties. Possible therapeutic applications of CBD contain, analgesic, anti-inflammatory, anxiolytic, anti-arthritic, anti-depressant, anti-Alzheimer illness, anti-ischemic, neuroprotective, and anti-fibrotic. A lot more promising regions seem to contain diabetes and cancer where CBD exhibits lesser side effects and additional therapeutic added benefits as compared to current available health-related therapies. Therefore, CBD is a promising substance for the improvement of new drug. Nevertheless additional investigation and clinical research are essential to discover its total prospective.
Copyright © 2018 Elsevier B.V. All rights reserved.
PMID: 29773016 DOI: 10.1615/CritRevEukaryotGeneExpr.2018021528
Noreen N1, Muhammad Ftwo, Akhtar Bthree, Azam F1, Anwar MIfour.